TRAVERE THERAPEUTICS, INC. Gain (Loss) Related to Litigation Settlement
TRAVERE THERAPEUTICS, INC. (TVTX) reported Gain (Loss) Related to Litigation Settlement of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-07-06.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2018-07-06
- TRAVERE THERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2017-09-30 was $0.00.
- TRAVERE THERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2017-06-30 was $0.00.
- TRAVERE THERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. gain (loss) related to litigation settlement for fiscal 2017 was $0.00.
- TRAVERE THERAPEUTICS, INC. gain (loss) related to litigation settlement for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- TRAVERE THERAPEUTICS, INC. gain (loss) related to litigation settlement for fiscal 2015 was $15.50M.
- TRAVERE THERAPEUTICS, INC. gain (loss) related to litigation settlement for fiscal 2014 was $0.00.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 6 month as first filed | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 9 month as first filed | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | $0.00 derived: sum of 2 quarters · filed 2018-07-06 | $0.00 derived: sum of 3 quarters · filed 2018-07-06 | $0.00 10-K · filed 2018-07-06 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $5.21M derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | $5.21M derived: sum of 3 quarters · filed 2018-07-06 | $5.21M derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-05 | $5.21M derived: sum of 2 quarters · filed 2018-07-06 | $5.21M derived: sum of 3 quarters · filed 2018-07-06 | $5.21M derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2016-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | $5.21M derived: sum of 2 quarters · filed 2018-07-06 | $5.21M derived: sum of 3 quarters · filed 2018-07-06 | $0.00 10-K · filed 2018-07-06 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | -$5.21M 10-Q · filed 2017-11-07 | $0.00 10-Q · filed 2016-11-04 | $2.97M derived: sum of 4 quarters · filed 2018-07-06 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-05 | $2.97M 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2016-08-05 | $2.97M derived: sum of 3 quarters · filed 2018-07-06 | $2.97M derived: sum of 4 quarters · filed 2018-07-06 | |
| 2016-03-31 | $2.97M 10-Q · filed 2017-05-05 | $2.97M derived: sum of 2 quarters · filed 2018-07-06 | $2.97M derived: sum of 3 quarters · filed 2018-07-06 | $18.47M derived: sum of 4 quarters · filed 2018-07-06 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | $0.00 derived: sum of 2 quarters · filed 2018-07-06 | $15.50M derived: sum of 3 quarters · filed 2018-07-06 | $15.50M 10-K · filed 2018-07-06 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-04 | $15.50M derived: sum of 2 quarters · filed 2016-11-04 | $15.50M 10-Q · filed 2016-11-04 | |||
| 2015-06-30 | $15.50M 10-Q · filed 2016-08-05 | $15.50M 10-Q · filed 2016-08-05 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | ||||
| 2013-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |